Longitudinal observation and outcome of nonfamilial childhood haemophagocytic syndrome receiving etoposide‐containing regimens

The long‐term outcome of 22 children treated with etoposide‐containing regimens for haemophagocytic syndrome (HS) were longitudinally studied; none of them had a family history of the disease. All patients received etoposide‐containing (150 mg/m2/d) regimens, combined, in 16 cases, with intravenous...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of haematology 1998-12, Vol.103 (3), p.756-762
Hauptverfasser:	Chen, Jiann‐Shiuh, Lin, Kai‐Hsin, Lin, Dong‐Tsamn, Chen, Rong‐Long, Jou, Shiann‐Tarng, Su, Ih‐Jen
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Antineoplastic agents Antineoplastic Agents, Hormonal - administration & dosage Antineoplastic Agents, Phytogenic - administration & dosage Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences Chemotherapy Child Child, Preschool Disease-Free Survival Epstein‐Barr virus etoposide Etoposide - administration & dosage Female haemophagocytic syndrome Hematology Herpesviridae Infections - complications Histiocytosis, Non-Langerhans-Cell - drug therapy Histiocytosis, Non-Langerhans-Cell - virology Humans Infant Karyotyping Longitudinal Studies Male Medical sciences Pharmacology. Drug treatments Prednisolone - administration & dosage RNA, Viral - isolation & purification survival Treatment Outcome T‐cell lymphoma
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!